Pacheco Rhonda Janice
President, U.S. Business Unit
Pacheco Rhonda Janice has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Aug 13, 2026.
On the most recent filing, Pacheco Rhonda Janice is listed as President, U.S. Business Unit at TAKEDA PHARMACEUTICAL CO LTD. Inside the rolling window, Pacheco Rhonda Janice reported no open-market purchases and 1 open-market sale totaling $289K in TAK.
Companies traded
Other insiders at TAK
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$289K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Pacheco Rhonda Janice made?
Pacheco Rhonda Janice has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Pacheco Rhonda Janice trade?
Pacheco Rhonda Janice has filed SEC Form 4 disclosures for 1 company, including TAK.
When was Pacheco Rhonda Janice's most recent SEC Form 4 filing?
Pacheco Rhonda Janice's most recent SEC Form 4 filing on Tracefour is dated Aug 13, 2026.
What is Pacheco Rhonda Janice's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Pacheco Rhonda Janice is listed as President, U.S. Business Unit.
What is Pacheco Rhonda Janice's total buy and sell value in the current window?
Inside the rolling retention window, Pacheco Rhonda Janice bought $0 and sold $289K based on SEC Form 4 filings.
What was Pacheco Rhonda Janice's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 16,901 TAK shares on 2026-08-10, worth $289K, per SEC Form 4 filings.